Viatris launches tender offer to acquire Pacira BioSciences for $36.50 a share

VTRS•2026-10-30

Viatris commenced a cash tender offer on Oct. 30, 2026, to acquire all outstanding Pacira BioSciences shares for $36.50 each. The offer expires Nov. 16 unless extended or terminated earlier.

Viatris launches tender offer to acquire Pacira BioSciences for $36.50 a share

1. Tender offer terms

Related News

Biddance Ai Systems completes acquisition of Ju Fu

US labor costs rise moderately in third quarter

Alps Group sets 1-for-5 share consolidation effective Nov. 9

BDO Canada partners with ServiceNow to help organizations govern AI and simplify operations

Taiwan's GigaMedia Q3 revenue rises on IP collaboration for game event